胆囊意外癌的评估与处理
Evaluation and management of incidental gallbladder cancer.
作者信息
Zaidi Mohammad Y, Abou-Alfa Ghassan K, Ethun Cecilia G, Shrikhande Shailesh V, Goel Mahesh, Nervi Bruno, Primrose John, Valle Juan W, Maithel Shishir K
机构信息
Division of Surgical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Medical College at Cornell University, New York, NY, USA.
出版信息
Chin Clin Oncol. 2019 Aug;8(4):37. doi: 10.21037/cco.2019.07.01. Epub 2019 Aug 5.
Abstract
Given the ubiquity of laparoscopic cholecystectomy in the modern era, the incidence of incidentally diagnosed gallbladder cancers (GBCs) is rising. This unique clinical scenario poses specific challenges regarding the role of staging, re-resection, and adjuvant treatment for patients with this disease. This review will address these controversies with the latest published data.
摘要
鉴于腹腔镜胆囊切除术在现代的广泛应用，偶然诊断出的胆囊癌（GBC）的发病率正在上升。这种独特的临床情况给该病患者的分期、再次切除和辅助治疗的作用带来了特殊挑战。本综述将结合最新发表的数据探讨这些争议。
相似文献
1
Evaluation and management of incidental gallbladder cancer.
Chin Clin Oncol. 2019 Aug;8(4):37. doi: 10.21037/cco.2019.07.01. Epub 2019 Aug 5.
2
Managing the incidentally detected gallbladder cancer: algorithms and controversies.
Int J Surg. 2014;12 Suppl 2:S108-S119. doi: 10.1016/j.ijsu.2014.08.367. Epub 2014 Aug 23.
3
Systematic review of management of incidental gallbladder cancer after cholecystectomy.
Br J Surg. 2019 Jan;106(1):32-45. doi: 10.1002/bjs.11035.
4
Gallbladder Cancer: Diagnosis, Surgical Management, and Adjuvant Therapies.
Surg Clin North Am. 2019 Apr;99(2):337-355. doi: 10.1016/j.suc.2018.12.008.
5
Adverse Outcomes After Bile Spillage in Incidental Gallbladder Cancers: A Population-based Study.
Ann Surg. 2021 Jan 1;273(1):139-144. doi: 10.1097/SLA.0000000000003325.
6
[Immediate radical re-resection of incidental T1b gallbladder cancer and the problem of an adequate extent of resection (results of the German Registry "Incidental Gallbladder Cancer")].
Zentralbl Chir. 2014 Dec;139 Suppl 2:e43-8. doi: 10.1055/s-0030-1262698. Epub 2011 Mar 1.
7
Gallbladder cancer: the role of laparoscopy and radical resection.
Ann Surg. 2007 Jun;245(6):893-901. doi: 10.1097/SLA.0b013e31806beec2.
8
Surgical Management of Gallbladder Cancer: Simple Versus Extended Cholecystectomy and the Role of Adjuvant Therapy.
Ann Surg. 2017 Oct;266(4):625-631. doi: 10.1097/SLA.0000000000002385.
9
Long-term outcomes of surgical resection for T1b gallbladder cancer: an institutional evaluation.
BMC Cancer. 2020 Jan 6;20(1):20. doi: 10.1186/s12885-019-6507-2.
10
Evolving treatment strategies for gallbladder cancer.
Ann Surg Oncol. 2009 Aug;16(8):2101-15. doi: 10.1245/s10434-009-0538-x. Epub 2009 Jun 3.
引用本文的文献
1
Bile spillage in incidental gallbladder cancer is not an independent predictor for survival: A multi-institute retrospective cohort study.
World J Gastrointest Surg. 2025 Jul 27;17(7):106919. doi: 10.4240/wjgs.v17.i7.106919.
2
Expression of inflammatory proteins STAT & NFĸB for phenotypic diagnosis of gall bladder cancer: A pilot study.
Indian J Med Res. 2025 Apr;161(4):414-419. doi: 10.25259/IJMR_1461_2024.
3
Neoadjuvant treatment for incidental gallbladder cancer: A systematic review.
Ann Hepatobiliary Pancreat Surg. 2025 May 31;29(2):113-120. doi: 10.14701/ahbps.24-223. Epub 2025 Mar 11.
4
Transabdominal ultrasound evaluation of vascularity of gallbladder lesions: particularly those with wall thickening.
J Med Ultrason (2001). 2024 Jul;51(3):429-436. doi: 10.1007/s10396-024-01467-3. Epub 2024 Jun 16.
5
A Retrospective Analysis of Incidental Gallbladder Cancer on Post-cholecystectomy Pathological Review.
Cureus. 2023 Oct 18;15(10):e47249. doi: 10.7759/cureus.47249. eCollection 2023 Oct.
6
Mucinous Adenocarcinoma of Gallbladder: An Incidental Finding of Acute Cholecystitis With Cholelithiasis.
Cureus. 2023 Jun 28;15(6):e41089. doi: 10.7759/cureus.41089. eCollection 2023 Jun.
7
Characteristics and outcomes of gallbladder cancer patients at the Tata Medical Center, Kolkata 2017-2019.
Cancer Med. 2023 Apr;12(8):9293-9302. doi: 10.1002/cam4.5677. Epub 2023 Feb 13.
8
The diagnostic value of staging laparoscopy in gallbladder cancer: a nationwide cohort study.
World J Surg Oncol. 2023 Jan 14;21(1):6. doi: 10.1186/s12957-022-02880-z.
9
Gallbladder cancer.
Nat Rev Dis Primers. 2022 Oct 27;8(1):69. doi: 10.1038/s41572-022-00398-y.
10
Incidental gallbladder cancer: a retrospective clinical study of 40 cases.
Ann Surg Treat Res. 2022 Apr;102(4):185-192. doi: 10.4174/astr.2022.102.4.185. Epub 2022 Apr 5.
本文引用的文献
1
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.
Lancet Oncol. 2019 May;20(5):663-673. doi: 10.1016/S1470-2045(18)30915-X. Epub 2019 Mar 25.
2
Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline.
J Clin Oncol. 2019 Apr 20;37(12):1015-1027. doi: 10.1200/JCO.18.02178. Epub 2019 Mar 11.
3
F-fluorodeoxyglucose positron emission tomography (FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis.
J Hepatol. 2019 Jul;71(1):115-129. doi: 10.1016/j.jhep.2019.01.038. Epub 2019 Feb 21.
4
Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study.
J Clin Oncol. 2019 Mar 10;37(8):658-667. doi: 10.1200/JCO.18.00050. Epub 2019 Feb 1.
5
A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT).
Jpn J Clin Oncol. 2018 Apr 1;48(4):392-395. doi: 10.1093/jjco/hyy004.
6
Emerging role of multimodality treatment in gall bladder cancer: Outcomes following 510 consecutive resections in a tertiary referral center.
J Surg Oncol. 2018 Mar;117(3):372-379. doi: 10.1002/jso.24837. Epub 2017 Sep 20.
7
8
Routine port-site excision in incidentally discovered gallbladder cancer is not associated with improved survival: A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium.
J Surg Oncol. 2017 Jun;115(7):805-811. doi: 10.1002/jso.24591. Epub 2017 Feb 23.
9
A Novel Pathology-Based Preoperative Risk Score to Predict Locoregional Residual and Distant Disease and Survival for Incidental Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium.
Ann Surg Oncol. 2017 May;24(5):1343-1350. doi: 10.1245/s10434-016-5637-x. Epub 2016 Nov 3.
10
Association of Optimal Time Interval to Re-resection for Incidental Gallbladder Cancer With Overall Survival: A Multi-Institution Analysis From the US Extrahepatic Biliary Malignancy Consortium.
JAMA Surg. 2017 Feb 1;152(2):143-149. doi: 10.1001/jamasurg.2016.3642.
Zotero 插件